Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
08/19EVOLVA : secures equity financing of up to CHF 30 million and provides further preliminary financials for 2016
PU
08/19EVOLVA : receives a notice from US EPA on its next-generation active ingredient against ticks and mosquitoes
PU
08/19EVOLVA : Joint venture to bring EverSweet TM sweeteners to market faster is finalized
PU
08/19EVOLVA : Gerard Hoetmer, formerly at Unilever and Corbion, proposed to succeed Sir Tom McKillop as Evolva Chairman
PU
08/19EVOLVA : publishes financial results for 2016 and updates on projects
PU
08/19EVOLVA : shareholders approve all AGM proposals that voted on Board of Directors withdraws three proposals prior to vote
PU
08/19EVOLVA : achieves second milestone in fragrance & flavour alliance with Takasago
PU
08/19EVOLVA : provides update on stevia collaboration and 2016 preliminary top-line numbers
PU
08/19EVOLVA : Neil Goldsmith stepping down as CEO and Board member of Evolva
PU
08/19EVOLVA : Scott Fabro to join Evolva as chief commercial officer
PU
08/19EVOLVA : announces long-term commercial agreement with Cargill
PU
08/19BERGENBIO ASA : Results for the Second Quarter and First Half 2019
AQ
08/18MPX BIOCEUTICAL : The green rush Thriving medical cannabis industry gets some towns' blessings
AQ
08/18EXELIXIS : Blue Faery Welcomes Exelixis to its Corporate Council
AQ
08/17SMITH & NEPHEW : U.S. Patents Awarded to Inventors in South Carolina (Aug. 17)
AQ
Discover
08/19BTG : Form 8.5 (EPT/RI) BTG plc
PU
08/19EVOTEC SE : Notification and public disclosure of transactions by persons
EQ
08/19CONVATEC : John McAdam appointed Chairman of ConvaTec 19 August 2019
PU
08/19FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
08/19BTG : Scheme becomes Effective
PU
08/19DR REDDY LABORATORIES : announces the launch of Versavo® (bevacizumab biosimilar) in India
BU
08/19Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide
GL
08/19Chemesis International Inc. to Begin Process of Obtaining NSF Facility Certification & Health Canada Certification for its Tobacco-Free Chew Products
GL
08/19BTG : Temporary Suspension BTG PLC
PU
08/19Europe’s Explosive CBD Market Now on Course for 400% Growth
AQ
08/19PHARMACOLOG I UPPSALA PUBL : hires sales manager in USA
AQ
08/19REDX PHARMA : First cohort of patients dosed in RXC004 study
PU
08/19Yield Growth Announces its Lip Balm with Hemp Oil Passes European Union Compliance Review and 250,000 Units now being Manufactured
NE
08/19BOSTON SCIENTIFIC : Daily Mail, London, Business Briefs
AQ
08/19YIELD GROWTH : Announces its Lip Balm with Hemp Oil Passes European Union Compliance Review and 250,000 Units now being Manufactured
AQ
08/19PHSC : Annual Financial Report
PR
08/19ASTRAZENECA : Directorate Change
AQ
08/19NIH to Evaluate Iclaprim Activity against Listeria
GL
08/19EVOLVA : Stuart Strathdee to retire from the Board of Directors of Evolva
PU
08/19EVOLVA : After successfully completing its transformation, Evolva is on track to build its business
PU
08/19EVOLVA : to publish half-year results on 21 August 2019
PU
08/19EVOLVA : shareholders approve all Board proposals at AGM
PU
08/19RESEARCHERS AT BRISTOL-MYERS SQUIBB COMPANY REPORT NEW DATA ON MEDICINAL CHEMISTRY (DISCOVERY OF POTENT PROTEASE-ACTIVATED RECEPTOR 4 ANTAGONISTS WITH IN VIVO ANTITHROMBOTIC EFFICACY) : Health and Medicine - Medicinal Chemistry
AQ
08/19RESEARCHERS SUBMIT PATENT APPLICATION, “PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY”, FOR APPROVAL (USPTO 20190231881) : Foresee Pharmaceuticals Co. Ltd.
AQ
08/19RECENT STUDIES FROM BOSTON UNIVERSITY ADD NEW DATA TO CARDIOVASCULAR ELECTROPHYSIOLOGY (HIGH IMPEDANCE ALERT WITH SAFETY SWITCHING : an Unreported Hazard of Hybrid Pacing Systems): Health and Medicine - Cardiovascular Electrophysiology
AQ
08/19ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR IDP-123 TREATMENT FOR ACNE VULGARIS IN LOTION FORM : Bausch Health Companies Inc.
AQ
08/19A RANDOMIZED, MULTI-CENTER, PHASE 3 STUDY OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB COMPARED TO SORAFENIB OR LENVATINIB AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH ADVANCED HEPATOCELLULAR CARCINOMA : Oncology - Liver Cancer
AQ
08/19INNOVENT AND SHENOGEN ANNOUNCE COLLABORATION TO EVALUATE TYVYT® SINTILIMAB INJECTION IN COMBINATION WITH SNG1005 FOR THE TREATMENT OF PATIENTS WITH ADVANCED CANCER : Innovent Biologics Inc.
AQ
08/19PATENT ISSUED FOR METHODS OF TREATMENT USING CTLA4 MUTANT MOLECULES (USPTO 10,370,428) : Bristol-Myers Squibb Company
AQ
08/19AN APPLICATION FOR THE TRADEMARK “INFUGEM” HAS BEEN FILED BY SUN PHARMACEUTICAL INDUSTRIES : Sun Pharmaceutical Industries
AQ
08/19INVESTIGATORS AT SCHOOL OF CIVIL AND ENVIRONMENTAL ENGINEERING REPORT FINDINGS IN ASTHMA (THE IMPACTS OF PRESCRIBED FIRE ON PM2.5 AIR QUALITY AND HUMAN HEALTH : Application to Asthma-Related Emergency Room Visits in Georgia, USA): Lung Diseases and Conditions - Asthma
AQ
08/19AN APPLICATION FOR THE TRADEMARK “EXPERIMENTAL AND APPLIED SCIENCES” HAS BEEN FILED BY ABBOTT LABORATORIES : Abbott Laboratories
AQ
08/19RESEARCHERS FROM GLAXOSMITHKLINE PLC DESCRIBE FINDINGS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE : Lung Diseases and Conditions - Chronic Obstructive Pulmonary Disease
AQ
08/19NINEPOINT MEDICAL ANNOUNCES FDA CLEARANCE FOR PANCREATIC AND BILIARY APPLICATIONS OF THE NVISIONVLE® IMAGING SYSTEM : NinePoint Medical Inc.
AQ
08/19PATENT ISSUED FOR MODULAR PATIENT ADAPTER FOR AN EYE LASER DEVICE (USPTO 10,369,055) : Novartis AG
AQ
08/19PATENT ISSUED FOR ADMINISTRATION OF POLYNUCLEOTIDE TOLL-LIKE RECEPTOR 9 AGONISTS FOR TREATING CANCER (USPTO 10,369,168) : Dynavax Technologies Corporation
AQ
08/19CHEMED CORPORATION DECLARES QUARTERLY DIVIDEND OF 32 CENTS : Chemed Corporation
AQ
08/19TRADEMARK APPLICATION FOR “BCARTES” FILED BY GILEAD SCIENCES : Gilead Sciences
AQ
08/19AN APPLICATION FOR THE TRADEMARK “BECARTSA” HAS BEEN FILED BY GILEAD SCIENCES : Gilead Sciences
AQ
08/19DATA FROM GLAXOSMITHKLINE PLC PROVIDE NEW INSIGHTS INTO HIV/AIDS (MECHANISTIC BASIS OF CABOTEGRAVIR-GLUCURONIDE DISPOSITION IN HUMANS) : Immune System Diseases and Conditions - HIV/AIDS
AQ
08/19RESEARCHERS SUBMIT PATENT APPLICATION, “MEDICAL TREATMENT APPARATUS AND OPERATION METHOD FOR MEDICAL TREATMENT APPARATUS”, FOR APPROVAL (USPTO 20190231382) : Olympus Corporation
AQ
08/19PATENT ISSUED FOR PATCH COMPRISING AN ADHESIVE LAYER HAVING A NONFUNCTIONAL SILICONE OIL (USPTO 10,369,116) : Hisamitsu Pharmaceutical Co. Inc.
AQ
08/19ANOTHER SUCCESS : IceCure Receives Israeli AMAR Approval for Use of its Freezing Technology in Specific Indications, Following an Earlier General Approval: IceCure Medical
AQ
08/19NEW FINDINGS FROM DEPARTMENT OF NEUROLOGY IN THE AREA OF MOLECULAR MEDICINE REPORTED (MIR-153 PROMOTES NEURAL DIFFERENTIATION IN THE MOUSE HIPPOCAMPAL HT-22 CELL LINE AND INCREASES THE EXPRESSION OF NEURON-SPECIFIC ENOLASE) : Health and Medicine - Molecular Medicine
AQ
08/19INVESTIGATORS AT UNIVERSITY OF PATRAS HAVE REPORTED NEW DATA ON MOLECULAR MEDICINE (ELIMINATION OF KLK5 INHIBITS EARLY SKIN TUMORIGENESIS BY REDUCING EPIDERMAL PROTEOLYSIS AND REINFORCING EPIDERMAL MICROSTRUCTURE) : Health and Medicine - Molecular Medicine
AQ
08/19“IMAGE PROCESSING DEVICE” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190238831) : Olympus Corporation
AQ
08/19FINDINGS FROM SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY PROVIDE NEW INSIGHTS INTO MOLECULAR MEDICINE (CYCLOPHILIN D PARTICIPATES IN THE INHIBITORY EFFECT OF HIGH-FAT DIET ON THE EXPRESSION OF STEROIDOGENIC ACUTE REGULATORY ...) : Biotechnology - Molecular Medicine
AQ
08/19NEW FINDINGS FROM AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH IN THE AREA OF MOLECULAR MEDICINE DESCRIBED (TOOLS FOR BIOIMAGING PANCREATIC BETA CELLS IN DIABETES) : Health and Medicine - Molecular Medicine
AQ
08/19“IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE RECORDING MEDIUM” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190238771) : Olympus Corporation
AQ
08/19NEW HUMAN PAPILLOMAVIRUS VACCINES FINDINGS FROM GLAXOSMITHKLINE PLC DESCRIBED (IMMUNOGENICITY OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE WHEN CO-ADMINISTERED WITH TETANUS-REDUCED DIPHTHERIA-ACELLULAR PERTUSSIS AND QUADRIVALENT MENINGOCOCCAL ...) : Immunization and Public Health - Human Papillomavirus Vaccines
AQ
Discover
08/19RESEARCHERS FROM TEVA PHARMACEUTICAL INDUSTRIES LTD. DETAIL FINDINGS IN OPIOIDS (EVALUATION OF THE RELATIVE INTRANASAL ABUSE POTENTIAL OF A HYDROCODONE EXTENDED-RELEASE TABLET FORMULATED WITH ABUSE-DETERRENCE TECHNOLOGY IN NONDEPENDENT, ...) : Opioids
AQ
08/19PATENT APPLICATION TITLED “SYSTEM AND METHOD FOR MANAGING VISUAL PRODUCT PLACEMENT” PUBLISHED ONLINE (USPTO 20190236526) : Veeva Systems Inc.
AQ
08/19ALNYLAM ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION FDA GRANTED PRIORITY REVIEW OF THE GIVOSIRAN NEW DRUG APPLICATION NDA FOR THE TREATMENT OF ACUTE HEPATIC PORPHYRIA : Alnylam Pharmaceuticals Inc.
AQ
08/19RESPIRATORY CONTROL AND PREVENTION OF OPIOID-INDUCED RESPIRATORY DEPRESSION AFTER SURGERY : Opioids
AQ
08/19NEW FINDINGS REPORTED FROM NATIONAL HUMAN GENOME RESEARCH INSTITUTE DESCRIBE ADVANCES IN ENDOMETRIAL CANCER (CLINICAL ACTIONABILITY OF MOLECULAR TARGETS IN ENDOMETRIAL CANCER) : Oncology - Endometrial Cancer
AQ
Prev.2  3  4  5  6   7  8  9  10  11Next
Advertisement